Literature DB >> 21911095

A truncation mutant of Csf3r cooperates with PML-RARα to induce acute myeloid leukemia in mice.

Ghada Kunter1, Jill R Woloszynek, Daniel C Link.   

Abstract

Severe congenital neutropenia is associated with a marked propensity to develop myelodysplasia or acute myeloid leukemia (AML). Truncation mutations of CSF3R, encoding the granulocyte colony-stimulating factor receptor (G-CSFR), are associated with development of myelodysplasia/AML in severe congenital neutropenia. However, a causal relationship between CSF3R mutations and leukemic transformation has not been established. Herein, we show that truncated G-CSFR cooperates with the PML-RARα oncogene to induce AML in mice. Expression of truncated G-CSFR significantly shortens the latency of AML in a G-CSF-dependent fashion and it is associated with a distinct AML presentation characterized by higher blast counts and more severe myelosuppression. Basal and G-CSF-induced signal transducer and activator of transcription 3, signal transducer and activator of transcription 5, and extracellular signal-regulated kinase 1/2 phosphorylation were highly variable but similar in leukemic blasts expressing wild-type and truncated G-CSFR. These data provide new evidence suggesting a causative role for CSF3R mutations in human AML.
Copyright © 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911095      PMCID: PMC3221305          DOI: 10.1016/j.exphem.2011.08.013

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  36 in total

1.  Stat5 tetramer formation is associated with leukemogenesis.

Authors:  Richard Moriggl; Veronika Sexl; Lukas Kenner; Christopher Duntsch; Katharina Stangl; Sebastien Gingras; Angelika Hoffmeyer; Anton Bauer; Roland Piekorz; Demin Wang; Kevin D Bunting; Erwin F Wagner; Karoline Sonneck; Peter Valent; James N Ihle; Hartmut Beug
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

2.  G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth.

Authors:  Quan-Sheng Zhu; Ling Xia; Gordon B Mills; Clifford A Lowell; Ivo P Touw; Seth J Corey
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

3.  JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.

Authors:  D P Steensma; R F McClure; J E Karp; A Tefferi; T L Lasho; H L Powell; G W DeWald; S H Kaufmann
Journal:  Leukemia       Date:  2006-06       Impact factor: 11.528

4.  Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Authors:  Jean Donadieu; Thierry Leblanc; Brigitte Bader Meunier; Mohamed Barkaoui; Odile Fenneteau; Yves Bertrand; Micheline Maier-Redelsperger; Marguerite Micheau; Jean Louis Stephan; Noel Phillipe; Pierre Bordigoni; Annie Babin-Boilletot; Philippe Bensaid; Anne Marie Manel; Etienne Vilmer; Isabelle Thuret; Stephane Blanche; Eliane Gluckman; Alain Fischer; Françoise Mechinaud; Bertrand Joly; Thierry Lamy; Olivier Hermine; Bruno Cassinat; Christine Bellanné-Chantelot; Christine Chomienne
Journal:  Haematologica       Date:  2005-01       Impact factor: 9.941

5.  Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.

Authors:  Daniel C Link; Ghada Kunter; Yumi Kasai; Yu Zhao; Tracie Miner; Michael D McLellan; Rhonda E Ries; Deepak Kapur; Rakesh Nagarajan; David C Dale; Audrey Anna Bolyard; Laurence A Boxer; Karl Welte; Cornelia Zeidler; Jean Donadieu; Christine Bellanné-Chantelot; James W Vardiman; Michael A Caligiuri; Clara D Bloomfield; John F DiPersio; Michael H Tomasson; Timothy A Graubert; Peter Westervelt; Mark Watson; William Shannon; Jack Baty; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Journal:  Blood       Date:  2007-05-09       Impact factor: 22.113

6.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Authors:  Philip S Rosenberg; Blanche P Alter; Audrey A Bolyard; Mary Ann Bonilla; Laurence A Boxer; Bonnie Cham; Carol Fier; Melvin Freedman; George Kannourakis; Sally Kinsey; Beate Schwinzer; Connie Zeidler; Karl Welte; David C Dale
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

7.  Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.

Authors:  M L McLemore; J Poursine-Laurent; D C Link
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

8.  STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.

Authors:  Hein Schepers; Djoke van Gosliga; Albertus T J Wierenga; Bart J L Eggen; Jan Jacob Schuringa; Edo Vellenga
Journal:  Blood       Date:  2007-07-13       Impact factor: 22.113

9.  Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.

Authors:  Z Xia; M R Baer; A W Block; H Baumann; M Wetzler
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

10.  Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.

Authors:  Yuko Kato; Atsushi Iwama; Yuko Tadokoro; Kazuya Shimoda; Mayu Minoguchi; Shizuo Akira; Minoru Tanaka; Atsushi Miyajima; Toshio Kitamura; Hiromitsu Nakauchi
Journal:  J Exp Med       Date:  2005-07-04       Impact factor: 14.307

View more
  13 in total

Review 1.  Mechanisms of leukemic transformation in congenital neutropenia.

Authors:  Daniel C Link
Journal:  Curr Opin Hematol       Date:  2019-01       Impact factor: 3.284

2.  Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib.

Authors:  T L Lasho; A Mims; M A Elliott; C Finke; A Pardanani; A Tefferi
Journal:  Leukemia       Date:  2014-01-21       Impact factor: 11.528

3.  Validation is a dish oft served cold.

Authors:  David B Wilson
Journal:  Blood       Date:  2014-06-12       Impact factor: 22.113

4.  Somatic mutations and clonal hematopoiesis in congenital neutropenia.

Authors:  Jun Xia; Christopher A Miller; Jack Baty; Amrita Ramesh; Matthew R M Jotte; Robert S Fulton; Tiphanie P Vogel; Megan A Cooper; Kelly J Walkovich; Vahagn Makaryan; Audrey A Bolyard; Mary C Dinauer; David B Wilson; Adrianna Vlachos; Kasiani C Myers; Robert J Rothbaum; Alison A Bertuch; David C Dale; Akiko Shimamura; Laurence A Boxer; Daniel C Link
Journal:  Blood       Date:  2017-11-01       Impact factor: 22.113

Review 5.  Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.

Authors:  Pankaj Dwivedi; Kenneth D Greis
Journal:  Exp Hematol       Date:  2016-10-24       Impact factor: 3.084

Review 6.  Genomics of chronic neutrophilic leukemia.

Authors:  Julia E Maxson; Jeffrey W Tyner
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

7.  CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

Authors:  A Pardanani; T L Lasho; R R Laborde; M Elliott; C A Hanson; R A Knudson; R P Ketterling; J E Maxson; J W Tyner; A Tefferi
Journal:  Leukemia       Date:  2013-04-22       Impact factor: 11.528

8.  The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition.

Authors:  Angela G Fleischman; Julia E Maxson; Samuel B Luty; Anupriya Agarwal; Lacey R Royer; Melissa L Abel; Jason D MacManiman; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  Blood       Date:  2013-09-30       Impact factor: 22.113

Review 9.  Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.

Authors:  Kim-Hien T Dao; Jeffrey W Tyner; Jason Gotlib
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

10.  Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

Authors:  Julia E Maxson; Jason Gotlib; Daniel A Pollyea; Angela G Fleischman; Anupriya Agarwal; Christopher A Eide; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Cristina E Tognon; J Blake Pond; Robert H Collins; Basem Goueli; Stephen T Oh; Michael W Deininger; Bill H Chang; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.